| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Z J Hall, S D Healy, S L Meddl. A role for nonapeptides and dopamine in nest-building behaviour. Journal of neuroendocrinology. vol 27. issue 2. 2015-10-21. PMID:25514990. |
because the nonapeptides, mesotocin and vasotocin and the neurotransmitter, dopamine, play important roles in avian social behaviour, we tested the hypothesis that mesotocinergic-vasotocinergic and dopaminergic neuronal populations in the social behaviour network and dopaminergic reward system, respectively, are active during nest building. |
2015-10-21 |
2023-08-13 |
Not clear |
| Chandana Buddhala, Susan K Loftin, Brandon M Kuley, Nigel J Cairns, Meghan C Campbell, Joel S Perlmutter, Paul T Kotzbaue. Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease. Annals of clinical and translational neurology. vol 2. issue 10. 2015-10-19. PMID:26478895. |
therefore, we quantified regional deficits in innervation from these pd-affected subcortical nuclei, by measuring the neurotransmitters and neurotransmitter transporter proteins originating from projections of dopaminergic neurons in substantia nigra pars compacta, serotonergic neurons in dorsal raphé nuclei, noradrenergic neurons in locus coeruleus, and cholinergic neurons in nucleus basalis of meynert. |
2015-10-19 |
2023-08-13 |
Not clear |
| Laurence de Fays, Karen Van Malderen, Karen De Smet, Javier Sawchik, Veerle Verlinden, Jamila Hamdani, Jean-Michel Dogné, Bernard Da. Use of paracetamol during pregnancy and child neurological development. Developmental medicine and child neurology. vol 57. issue 8. 2015-09-29. PMID:25851072. |
these effects may be mediated by interference of paracetamol with brain-derived neurotrophic factor, neurotransmitter systems (including serotonergic, dopaminergic, adrenergic, as well as the endogenous endocannabinoid systems), or cyclooxygenase-2. |
2015-09-29 |
2023-08-13 |
Not clear |
| Juho Joutsa, Jarkko Johansson, Marko Seppänen, Tommi Noponen, Valtteri Kaasine. Dorsal-to-Ventral Shift in Midbrain Dopaminergic Projections and Increased Thalamic/Raphe Serotonergic Function in Early Parkinson Disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. vol 56. issue 7. 2015-09-22. PMID:25952735. |
however, parkinson pathology is more widespread in the brain, affecting also other dopaminergic pathways and neurotransmitter systems, but these changes are less well characterized. |
2015-09-22 |
2023-08-13 |
Not clear |
| Eugene V Mosharov, Anders Borgkvist, David Sulze. Presynaptic effects of levodopa and their possible role in dyskinesia. Movement disorders : official journal of the Movement Disorder Society. vol 30. issue 1. 2015-09-11. PMID:25450307. |
we review how this dopamine (da) precursor enhances dopaminergic transmission by providing a greater sphere of neurotransmitter influence as a result of the confluence of increased quantal size and decreased da reuptake, as well as loading da as a false transmitter into surviving serotonin neuron synaptic vesicles. |
2015-09-11 |
2023-08-13 |
Not clear |
| Matea Nikolac Perkovic, Gordana Nedic Erjavec, Maja Zivkovic, Marina Sagud, Suzana Uzun, Alma Mihaljevic-Peles, Oliver Kozumplik, Dorotea Muck-Seler, Nela Piva. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients. Psychopharmacology. vol 231. issue 18. 2015-09-10. PMID:24595507. |
brain-derived neurotrophic factor (bdnf) is a neurotrophin that plays a major role in neurogenesis and neuroplasticity, and in the modulation of several neurotransmitter systems including the dopaminergic system. |
2015-09-10 |
2023-08-12 |
Not clear |
| Davide Amat. Serotonin in antipsychotic drugs action. Behavioural brain research. vol 277. 2015-09-08. PMID:25078293. |
there is general agreement that we are abusing dopaminergic based criteria to evaluate the newly available compounds although they are targeting several other neurotransmitter systems. |
2015-09-08 |
2023-08-13 |
rat |
| F Joseph McClernon, Merideth A Addicott, Maggie M Sweitze. Smoking abstinence and neurocognition: implications for cessation and relapse. Current topics in behavioral neurosciences. vol 23. 2015-09-08. PMID:25655892. |
in our review we identify smoking abstinence-induced deficits in executive function mediated by effects on frontal circuitry, which in turn is known to be affected by modulation of cholinergic, dopaminergic, and other neurotransmitter systems. |
2015-09-08 |
2023-08-13 |
Not clear |
| J Genius, A Schellenberg, L Tchana-Duope, N Hartmann, I Giegling, A Hartmann, J Benninghoff, D Rujesc. Enhanced calcium responses to serotonin receptor stimulation in T-lymphocytes from schizophrenic patients--a pilot study. Neuroscience letters. vol 589. 2015-08-27. PMID:25576705. |
our observations suggest that the participation of serotonergic neurotransmitter system in the pathogenesis of schizophrenia may deserve more interest, even if it should only act as a modulator on the main pathology in the dopaminergic and glutamatergic systems. |
2015-08-27 |
2023-08-13 |
Not clear |
| b' Monika Vrajov\\xc3\\xa1, Barbora Schutov\\xc3\\xa1, Jan Klaschka, Hana St\\xc4\\x9bp\\xc3\\xa1nkov\\xc3\\xa1, Daniela R\\xc3\\xadpov\\xc3\\xa1, Romana \\xc5\\xa0lamberov\\xc3\\xa. Age-related differences in NMDA receptor subunits of prenatally methamphetamine-exposed male rats. Neurochemical research. vol 39. issue 11. 2015-07-29. PMID:25079254.' |
ma exposure is associated with changes in the function of neurotransmitter systems, namely the dopaminergic, serotonergic and glutamatergic systems. |
2015-07-29 |
2023-08-13 |
rat |
| Xiaoqi Pan, Xiongxiong Guo, Fei Xiong, Guihong Cheng, Qing Lu, Hong Ya. Acrylamide increases dopamine levels by affecting dopamine transport and metabolism related genes in the striatal dopaminergic system. Toxicology letters. vol 236. issue 1. 2015-07-20. PMID:25943760. |
the neurotransmitter dopamine (da) has an increasingly important role in the dopaminergic system. |
2015-07-20 |
2023-08-13 |
rat |
| Marek J Jus. The influence of atypical antipsychotic drugs on sexual function. Neuropsychiatric disease and treatment. vol 11. 2015-07-18. PMID:26185449. |
variety of mechanisms are likely to contribute to antipsychotic-related sexual dysfunction, including hyperprolactinemia, sedation, and antagonism of a number of neurotransmitter receptors (α-adrenergic, dopaminergic, histaminic, and muscarinic). |
2015-07-18 |
2023-08-13 |
human |
| Jordan A Tharp, Carter Wendelken, Carol A Mathews, Elysa J Marco, Herbert Schreier, Silvia A Bung. Tourette Syndrome: Complementary Insights from Measures of Cognitive Control, Eyeblink Rate, and Pupil Diameter. Frontiers in psychiatry. vol 6. 2015-07-16. PMID:26175694. |
we hypothesize that observed tic severity reflects a combination of factors, including the degree to which dopaminergic (da) and/or noradrenergic (ne) neurotransmitter systems have been affected by the disorder, and the degree to which the child can exert cognitive control to suppress unwanted tics. |
2015-07-16 |
2023-08-13 |
Not clear |
| Noriya Watanabe, Miyuki Yamamot. Neural mechanisms of social dominance. Frontiers in neuroscience. vol 9. 2015-07-03. PMID:26136644. |
additionally, neurotransmitter systems such as the dopaminergic and serotonergic systems, modulate and are modulated by the formation of the social hierarchy in a group. |
2015-07-03 |
2023-08-13 |
Not clear |
| Jose Gómez, Juan Jesús Marín-Méndez, Patricio Molero, Zerrin Atakan, Felipe Ortuñ. Time perception networks and cognition in schizophrenia: a review and a proposal. Psychiatry research. vol 220. issue 3. 2015-06-29. PMID:25219610. |
there is also evidence that several neurotransmitter systems, particularly the dopaminergic d2 system, are involved in interval timing. |
2015-06-29 |
2023-08-13 |
human |
| W Wyatt Wilson, Wellington Onyenwe, Joshua M Bradner, Sadie E Nennig, W Michael Caudl. Developmental exposure to the organochlorine insecticide endosulfan alters expression of proteins associated with neurotransmission in the frontal cortex. Synapse (New York, N.Y.). vol 68. issue 11. 2015-06-26. PMID:25042905. |
elaborating these findings to an in vivo model we found that developmental exposure of female mice to endosulfan during gestation and lactation elicited significant alterations to the gabaergic (gat1, vgat, gabaa receptor), glutamatergic (vglut and glun2b receptor), and dopaminergic (dat, th, vmat2, and d2 receptor) neurotransmitter systems in the frontal cortex of male offspring. |
2015-06-26 |
2023-08-13 |
mouse |
| Rukmini Mridula Kandadai, Shaik Afshan Jabeen, Meena A Kanikannan, Rupam Borgohai. Safinamide for the treatment of Parkinson's disease. Expert review of clinical pharmacology. vol 7. issue 6. 2015-06-15. PMID:25300164. |
parkinson's disease (pd) is a neurodegenerative disease caused by a complex interaction of loss of dopaminergic and non-dopaminergic neurotransmitter systems. |
2015-06-15 |
2023-08-13 |
Not clear |
| Se Joon Choi, Anne Panhelainen, Yvonne Schmitz, Kristin E Larsen, Ellen Kanter, Min Wu, David Sulzer, Eugene V Mosharo. Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure. The Journal of biological chemistry. vol 290. issue 11. 2015-05-29. PMID:25596531. |
in contrast, depletion of intracellular da by blocking neurotransmitter synthesis resulted in ∼30% reduction of mpp(+)-mediated toxicity, whereas overexpression of vmat2 completely rescued dopaminergic neurons. |
2015-05-29 |
2023-08-13 |
mouse |
| Xiaoying Cui, Helen Gooch, Natalie J Groves, Pankaj Sah, Thomas H Burne, Darryl W Eyles, John J McGrat. Vitamin D and the brain: key questions for future research. The Journal of steroid biochemistry and molecular biology. vol 148. 2015-05-21. PMID:25448739. |
in particular, dvd deficiency is associated with alterations in the dopaminergic neurotransmitter systems. |
2015-05-21 |
2023-08-13 |
Not clear |
| Arthur M Butt, Robert F Fern, Carlos Matut. Neurotransmitter signaling in white matter. Glia. vol 62. issue 11. 2015-05-15. PMID:24753049. |
a surprising aspect is the diversity of neurotransmitter signaling in wm, with evidence for glutamatergic, purinergic (atp and adenosine), gabaergic, glycinergic, adrenergic, cholinergic, dopaminergic and serotonergic signaling, acting via a wide range of ionotropic and metabotropic receptors. |
2015-05-15 |
2023-08-13 |
human |